150 related articles for article (PubMed ID: 1768046)
1. Carcinogenesis and the response of tumours to anticancer drugs.
Keith WN; Brown R
Anticancer Res; 1991; 11(5):1739-43. PubMed ID: 1768046
[TBL] [Abstract][Full Text] [Related]
2. Cellular maturation and oncogene expression during drug-induced differentiation in vitro: a brief review.
Biedler JL; Spengler BA; Ross RA
Prog Clin Biol Res; 1990; 354A():287-312. PubMed ID: 2247493
[No Abstract] [Full Text] [Related]
3. [Oncogenes, antioncogenes and carcinogenesis].
Kopnin BP
Arkh Patol; 1990; 52(9):3-11. PubMed ID: 2270978
[TBL] [Abstract][Full Text] [Related]
4. Molecular interrelationships in multidrug resistance (review).
Kellen JA
Anticancer Res; 1994; 14(2A):433-5. PubMed ID: 8017843
[TBL] [Abstract][Full Text] [Related]
5. Predicting drug response based on gene expression.
Robert J; Vekris A; Pourquier P; Bonnet J
Crit Rev Oncol Hematol; 2004 Sep; 51(3):205-27. PubMed ID: 15331079
[TBL] [Abstract][Full Text] [Related]
6. Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
Patiar S; Harris AL
Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S61-75. PubMed ID: 17259560
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations and DNA repair in human carcinogenesis.
Dixon K; Kopras E
Semin Cancer Biol; 2004 Dec; 14(6):441-8. PubMed ID: 15489137
[TBL] [Abstract][Full Text] [Related]
8. p53 and response to chemotherapy and radiotherapy.
Ruley HE
Important Adv Oncol; 1996; ():37-56. PubMed ID: 8791127
[No Abstract] [Full Text] [Related]
9. The multidrug resistance gene in renal cell carcinoma.
Klein EA
Semin Urol; 1989 Nov; 7(4):207-14. PubMed ID: 2575783
[No Abstract] [Full Text] [Related]
10. Differentiation: an encouraging approach to anticancer therapy.
Marchal JA; Rodríguez-Serrano F; Campos J; Madeddu R; Boulaiz H; Martínez-Amat A; Carrillo E; Caba O; Prados JC; Vélez C; Melguizo C; Montella A; Aránega A
Ital J Anat Embryol; 2006; 111(1):45-64. PubMed ID: 16736717
[TBL] [Abstract][Full Text] [Related]
11. Mutations and altered expression of the human cancer genes: what they tell us about causes.
Devereux TR; Risinger JI; Barrett JC
IARC Sci Publ; 1999; (146):19-42. PubMed ID: 10353382
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB: tumor promoter or suppressor?
Perkins ND
Trends Cell Biol; 2004 Feb; 14(2):64-9. PubMed ID: 15102437
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of tumours derived from rasV12/E1A-transformed mouse embryonic fibroblasts to identify genes required for tumour development.
Vasseur S; Malicet C; Calvo EL; Dagorn JC; Iovanna JL
Mol Cancer; 2005 Jan; 4(1):4. PubMed ID: 15651998
[TBL] [Abstract][Full Text] [Related]
14. [Oncogenes as molecular basis of carcinogenesis].
de La Roche Saint André C
Bull Cancer; 1991 Jan; 78(1):49-56. PubMed ID: 2021686
[TBL] [Abstract][Full Text] [Related]
15. [Carcinogenesis: from epidemiology to molecular biology].
Tubiana M
Bull Acad Natl Med; 1998; 182(1):19-29; discussion 29-31. PubMed ID: 9622929
[TBL] [Abstract][Full Text] [Related]
16. Transformation effector and suppressor genes.
Boylan MO; Zarbl H
J Cell Biochem; 1991 Jul; 46(3):199-205. PubMed ID: 1774222
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of drug resistance.
Longley DB; Johnston PG
J Pathol; 2005 Jan; 205(2):275-92. PubMed ID: 15641020
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic resistance to growth-limiting conditions.
Blagosklonny MV
Nat Rev Cancer; 2002 Mar; 2(3):221-5. PubMed ID: 11990858
[TBL] [Abstract][Full Text] [Related]
19. [P53 protein: a new tool for the clinician?].
Laurent-Puig P
Gastroenterol Clin Biol; 1995 May; 19(5):463-4. PubMed ID: 7589996
[No Abstract] [Full Text] [Related]
20. [Pharmacokinetic mechanisms of resistance to anticancer medications].
Robert J
Bull Cancer; 1994 Dec; 81 Suppl 2():78s-81s. PubMed ID: 7727864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
